Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II Study. Cowzer D, Wu AJ, Sihag S, Walch HS, et al. Ann Surg 2023;278:e511-e518.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cowzer D, Wu AJ, Sihag S, Walch HS, et al. Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II Study. Ann Surg 2023;278:e511-e518.
PMID: 36762546